Page last updated: 2024-11-05

thalidomide and Abnormalities, Jaw

thalidomide has been researched along with Abnormalities, Jaw in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miehlke, A1
Schübel, F1
Partsch, CJ1

Reviews

1 review available for thalidomide and Abnormalities, Jaw

ArticleYear
[Combined abnormalities of the ear and eye].
    HNO, 1967, Volume: 15, Issue:4

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Craniofacial Dysostosis; Ear; Embryology; Eye

1967

Other Studies

1 other study available for thalidomide and Abnormalities, Jaw

ArticleYear
[Thalidomide-embryopathies and their effect on dentition].
    Deutsche zahnarztliche Zeitschrift, 1965, Dec-01, Volume: 20, Issue:12

    Topics: Abnormalities, Drug-Induced; Ectromelia; Female; Humans; Infant, Newborn; Jaw Abnormalities; Pregnan

1965